Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Outset Medical, Inc. Director's Dealing 2021

Oct 21, 2021

33476_dirs_2021-10-21_cc808317-6bb6-418b-ad82-50e0ae7dd785.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Outset Medical, Inc. (OM)
CIK: 0001484612
Period of Report: 2021-10-15

Reporting Person: Porter Stacey L. (Chief People Officer)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 11784.00 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $4.11 2028-12-12 Common Stock (31139.00) Direct
Non-Qualified Stock Option (right to buy) $6.25 2029-09-10 Common Stock (7898.00) Direct
Non-Qualified Stock Option (right to buy) $8.62 2030-02-03 Common Stock (1898.00) Direct
Non-Qualified Stock Option (right to buy) $46.94 2031-03-08 Common Stock (10296.00) Direct
Performance Options (right to buy) $4.11 2028-12-12 Common Stock (20759.00) Direct
Performance Options (right to buy) $6.25 2029-09-10 Common Stock (5265.00) Direct
Performance Options (right to buy) $8.62 2030-02-03 Common Stock (1265.00) Direct

Footnotes

F1: This option vests in 48 equal monthly installments beginning on December 12, 2018, subject to the reporting person's continued employment through the applicable
vesting date.

F2: This option vests in 48 equal monthly installments, subject to the reporting person's continuous service through the applicable vesting date.

F3: This option vests 25% on March 8, 2022 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the
applicable vesting date.

F4: All shares subject to this grant fully vested on March 15, 2021, after meeting performance criteria.